Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02584270 · ClinicalTrials.gov registry record · NA
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
A NA study of Oral Cancer and Tongue Cancer, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02584270 is a NA study of Oral Cancer and Tongue Cancer that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02584270, a NA study of Oral Cancer and Tongue Cancer, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis (PAP) as a therapeutic modality post-surgery. This is a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential to dramatically alter the most common issues of oral cancer therapy, namely speech and swallowing functions. Patients will have been diagnosed with a cancer lesion of the tongue requiring surgery and removal of part of the tongue. Smaller cancers of the tongue are sized as T1 or T2. For patients with smaller lesions, a PAP, which can aid in speaking and swallowing, is not routinely provided.
Conditions Studied
Interventions
- DEVICE Palatal Augmentation Prosthesis (PAP)
- OTHER Articulation Therapy
Study Locations (1)
Michigan
- University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02584270
The ClinicalTrials.gov registry entry for NCT02584270 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (81% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Oral Cancer appearing as the primary indexed condition, and to 2 interventions - of which Palatal Augmentation Prosthesis (PAP) is the first listed.
NCT02584270 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02584270 about?
NCT02584270 is a clinical study titled "Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue". This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis (PAP) as a therapeutic modality post-surgery. This is a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential t...
What is the current status of trial NCT02584270?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-01-02. Estimated completion is 2026-06.
What conditions does trial NCT02584270 study?
This clinical trial studies the following conditions: Oral Cancer, Tongue Cancer, Tongue Neoplasms.
What interventions are being tested in trial NCT02584270?
The interventions under investigation include: Palatal Augmentation Prosthesis (PAP) (DEVICE), Articulation Therapy (OTHER).
Who is sponsoring clinical trial NCT02584270?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02584270 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oral Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
RECRUITING · NA
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
RECRUITING · NA
-
Enhancing Oral Cancer Awareness
RECRUITING · NA
-
Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
ACTIVE NOT RECRUITING · NA
-
Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.